Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and the ...

These can be classified in to those directed against cytokines involved in cell proliferation, survival and differentiation (i.e., IL-2, IL-4, IL-9 and IL-12), and those linked to the inflammatory ...

Please provide your email address to receive an email when new articles are posted on . Patients received omalizumab with placebo oral immunotherapy or vice versa. 88% of the omalizumab group and 51% ...

When asked about food allergy management, more individuals reported choosing allergen avoidance over oral immunotherapy or ...

The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...

Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma. Identifying triggers and avoiding exposure to substances that exacerbate ...

In all, 36% of children treated with omalizumab (Xolair) for a year successfully ate full servings of allergy-triggering foods, according to phase 2 trial results. Adobe stock/HealthDay More than a ...

Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other allergic conditions have improved the quality of care for seasonal allergies ...

What if instead of temporarily relieving your allergies with medication, you could train your immune system to stop overreacting to your allergens altogether? That’s the idea behind allergy ...

DelveInsight's House Dust Mite Disease Market Insights report includes a comprehensive understanding of current treatment practices, house dust mite disease emerging drugs, market share of individual ...